Literature DB >> 17219076

A case of fatal necrotizing pancreatitis: complication of hydrochlorothiazide and lisinopril therapy.

Sareen Bedrossian1, Bobbak Vahid.   

Abstract

We report a case of fatal necrotizing pancreatitis associated with hydrochlorothiazide and lisinopril therapy. A 49-year-old man who presented with 2 days of abdominal pain and vomiting was found to have severe pancreatitis. The patient denied any alcohol use. In addition, abdominal ultrasound examinations showed no evidence of cholelithiasis or bile duct dilations. Review of his medication history with the family revealed that he was being treated with hydrochlorothiazide and lisinopril for hypertension. An exploratory laparotomy was performed and revealed no common bile duct stones. Unfortunately, the patient's hospital course was complicated with multiple organ failure, which resulted in death. To the best of our knowledge, there are only 3 other reported cases of hydrochlorothiazide-induced necrotizing pancreatitis reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17219076     DOI: 10.1007/s10620-006-9220-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  Recurrent pancreatitis after treatment with hydrochlorothiazide.

Authors:  R J Rion
Journal:  J Am Board Fam Pract       Date:  1994 Jan-Feb

2.  Drug-induced pancreatitis: an update.

Authors:  Chirag D Trivedi; C S Pitchumoni
Journal:  J Clin Gastroenterol       Date:  2005-09       Impact factor: 3.062

Review 3.  Drug-induced pancreatitis: a critical review.

Authors:  A Mallory; F Kern
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

4.  Angiotensin-converting-enzyme inhibitor administration must be monitored for serum amylase and lipase in order to prevent an acute pancreatitis: a case report.

Authors:  M C Borgia; A Celestini; P Caravella; C Catalano
Journal:  Angiology       Date:  2001-09       Impact factor: 3.619

5.  Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in The Netherlands.

Authors:  I A Eland; E P van Puijenbroek; M J Sturkenboom; J H Wilson; B H Stricker
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 6.  Acute pancreatitis. A review with an emphasis on new developments.

Authors:  J B Marshall
Journal:  Arch Intern Med       Date:  1993-05-24

7.  Acute pancreatitis associated with the use of lisinopril.

Authors:  J Maliekal; C F Drake
Journal:  Ann Pharmacother       Date:  1993-12       Impact factor: 3.154

8.  Epidemiology and outcome of acute pancreatitis.

Authors:  S R Thomson; W S Hendry; G A McFarlane; A I Davidson
Journal:  Br J Surg       Date:  1987-05       Impact factor: 6.939

9.  Angiotensin-converting enzyme inhibitor-induced pancreatitis.

Authors:  J S Muchnick; J L Mehta
Journal:  Clin Cardiol       Date:  1999-01       Impact factor: 2.882

10.  Drug induced acute pancreatitis: incidence and severity.

Authors:  P G Lankisch; M Dröge; F Gottesleben
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

View more
  2 in total

1.  First report of telaprevir-induced pancreatitis.

Authors:  Carlos Ventura; Ryan Urich; Shannon Skinner; Robert Bina; Keng-Yu Chuang; David H Van Thiel; Abdul Nadir
Journal:  Dig Dis Sci       Date:  2013-02-08       Impact factor: 3.199

2.  A Drug-Induced Acute Pancreatitis Retrospective Study.

Authors:  Ann-Lorie Gagnon; Alexandre Lavoie; Marie-Pier Frigon; Alban Michaud-Herbst; Karine Tremblay
Journal:  Can J Gastroenterol Hepatol       Date:  2020-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.